Related Experiment Video
Updated: Jan 2, 2026
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
Published on: November 23, 2019
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
Keni Vidilaseris1, Niklas G Johansson2, Ainoleena Turku2
1Research Program in Molecular and Integrative Biosciences, University of Helsinki.
Abstract:
Membrane-bound pyrophosphatases (mPPases) are dimeric enzymes that occur in bacteria, archaea, plants, and protist parasites. These proteins cleave pyrophosphate into two orthophosphate molecules, which is coupled with proton and/or sodium ion pumping across the membrane. Since no homologous proteins occur in animals and humans, mPPases are good candidates in the design of potential drug targets. Here we present a detailed protocol to screen for mPPase inhibitors utilizing the molybdenum blue reaction in a 96 well plate system. We use mPPase from the thermophilic bacterium Thermotoga maritima (TmPPase) as a model enzyme. This protocol is simple and inexpensive, producing a consistent and robust result. It takes only about one hour to complete the activity assay protocol from the start of the assay until the absorbance measurement. Since the blue color produced in this assay is stable for a long period of time, subsequent assay(s) can be performed immediately after the previous batch, and the absorbance can be measured later for all batches at once. The drawback of this protocol is that it is done manually and thus can be exhausting as well as require good skills of pipetting and time keeping. Furthermore, the arsenite-citrate solution used in this assay contains sodium arsenite, which is toxic and should be handled with necessary precautions.
Insights
This study presents a simple, inexpensive molybdenum blue assay for screening membrane-bound pyrophosphatase (mPPase) inhibitors. The assay uses Thermotoga maritima mPPase (TmPPase) and offers robust results within an hour.
Area of Science:
- Biochemistry
- Enzymology
- Drug Discovery
Background:
- Membrane-bound pyrophosphatases (mPPases) are crucial enzymes in various organisms, catalyzing pyrophosphate hydrolysis coupled with ion transport.
- The absence of homologous mPPases in humans makes them attractive targets for drug development.
- Identifying inhibitors of mPPases could lead to novel therapeutic strategies.
Purpose of the Study:
- To develop and detail a robust, high-throughput screening protocol for identifying mPPase inhibitors.
- To establish a cost-effective and efficient method for mPPase activity assays.
- To utilize the molybdenum blue reaction for quantitative assessment of mPPase inhibition.
Main Methods:
- A 96-well plate assay system was established for screening mPPase inhibitors.
- The molybdenum blue reaction was employed to detect pyrophosphate hydrolysis products.
- The thermophilic bacterium Thermotoga maritima mPPase (TmPPase) was used as a model enzyme.
Main Results:
- The developed protocol provides simple, inexpensive, consistent, and robust results for mPPase inhibitor screening.
- The assay is rapid, with activity measurements completed within one hour.
- The assay allows for flexible batch processing and delayed absorbance measurements due to stable color development.
Conclusions:
- The described molybdenum blue assay is a practical and effective tool for screening mPPase inhibitors.
- This method facilitates the discovery of potential drug candidates targeting mPPases.
- While effective, the manual nature and use of toxic reagents require careful handling and skilled execution.
